MedTrace Logo

Narrow Band Imaging Versus White Light for Colonoscopy Serrate Lesions Detection

NCT02876133 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 987

Last updated 2018-09-26

No results posted yet for this study

Summary

Colorectal cancer (CRC) is a leading cause of cancer death and its' incidence is rising in most European countries. Colonoscopy has been shown to reduce CRC incidence, however its effectiveness depends on the sensitivity to detect pre-malignant lesions.

Our aim is to evaluate narrow band imaging (NBI) during colonoscopy and serum miRNAs as novel tools for the early detection of colonic sessile serrated lesions (SSL). The investigators will perform a multicenter-randomized-controlled-trial to study the role of NBI in SSL detection.

Conditions

Interventions

DEVICE

narrow band imaging withdrawal

colonoscope withdrawal and mucosal inspection performed under narrow band imaging

DEVICE

white light withdrawal

colonoscope withdrawal and mucosal inspection performed under white light imaging

Sponsors & Collaborators

  • Hospital Beatriz Ângelo

    lead OTHER

Principal Investigators

  • Alexandre O Ferreira, MD · Hospital Beatriz Ângelo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02876133 on ClinicalTrials.gov